ダウンロード数: 219
| タイトル: | 腎細胞癌の分子標的治療 (第56回日本泌尿器科学会中部総会) |
| その他のタイトル: | Molecular targeted therapy for renal cell carcinoma |
| 著者: | 水谷, 陽一  中西, 弘之 水野, 正明 吉田, 純 三木, 恒治 |
| 著者名の別形: | Mizutani, Yoichi Nakanishi, Hiroyuki Mizuno, Masaaki Yoshida, Jun Miki, Tsuneharu |
| キーワード: | Molecular targeted therapy Renal cell carcinoma Sunitinib Sorafenib Temsirolimus |
| 発行日: | Jan-2008 |
| 出版者: | 泌尿器科紀要刊行会 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 54 |
| 号: | 1 |
| 開始ページ: | 53 |
| 終了ページ: | 56 |
| 抄録: | Renal cell carcinoma (RCC) accounts for approximately 2% of all cancer cases worldwide. Metastatic disease is often present at the time of diagnosis of RCC and its poor response to chemotherapy and radiotherapy causes poor prognosis. Immunotherapy is relatively effective for RCC, but the response rate is approximately 15-20%. Therefore, new therapeutic approaches are necessary for these patients with metastatic RCC. Recently, the mechanisms responsible for the growth of RCC have been clarified, and molecular targeted therapy has been developed. In this paper, we review the new molecular targeted therapeutic agents effective for RCC. |
| URI: | http://hdl.handle.net/2433/71564 |
| PubMed ID: | 18260362 |
| 出現コレクション: | Vol.54 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。